These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
287 related items for PubMed ID: 8843956
1. Study of a new tumor marker, CYFRA 21-1, in squamous cell carcinoma of the cervix, and comparison with squamous cell carcinoma antigen. Tsai SC, Kao CH, Wang SJ. Neoplasma; 1996; 43(1):27-9. PubMed ID: 8843956 [Abstract] [Full Text] [Related]
2. Cytokeratin subunit 19 measured by CYFRA 21-1 assay in follow-up of cervical cancer. Kainz C, Sliutz G, Mustafa G, Bieglmayr C, Koelbl H, Reinthaller A, Gitsch G. Gynecol Oncol; 1995 Mar; 56(3):402-5. PubMed ID: 7535720 [Abstract] [Full Text] [Related]
3. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen. Bonfrer JM, Gaarenstroom KN, Korse CM, Van Bunningen BN, Kenemans P. Anticancer Res; 1997 Mar; 17(3C):2329-34. PubMed ID: 9245246 [Abstract] [Full Text] [Related]
9. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer. Tas F, Aydiner A, Topuz E, Yasasever V, Karadeniz A, Saip P. J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326 [Abstract] [Full Text] [Related]
10. Clinical usefulness of CYFRA 21-1 for esophageal squamous cell carcinoma in radiation therapy. Wakatsuki M, Suzuki Y, Nakamoto S, Ohno T, Ishikawa H, Kiyohara H, Kiyozuka M, Shirai K, Nakayama Y, Nakano T. J Gastroenterol Hepatol; 2007 May; 22(5):715-9. PubMed ID: 17444861 [Abstract] [Full Text] [Related]
11. Comparison of CYFRA 21-1 and tissue polypeptide specific antigen (TPS) for detecting nasopharyngeal carcinoma. Tai CJ, Liu FY, Liang JA, Yang SN, Tsai MH, Kao CH. Anticancer Res; 2002 May; 22(6B):3793-6. PubMed ID: 12552995 [Abstract] [Full Text] [Related]
12. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck. Inal E, Laçin M, Asal K, Ceylan A, Köybaşioğlu A, Ileri F, Uslu SS. Kulak Burun Bogaz Ihtis Derg; 2004 May; 12(1-2):23-30. PubMed ID: 16010093 [Abstract] [Full Text] [Related]
13. [A comparison of serum Cyfra 21-1 and SCC AG in the diagnosis of squamous cell esophageal carcinoma]. Ychou M, Khemissa-Akouz F, Kramar A, Senesse P, Grenier J. Bull Cancer; 2001 Oct; 88(10):1023-7. PubMed ID: 11713038 [Abstract] [Full Text] [Related]
14. Prognostic significance of serum fragments of cytokeratin 19 measured by Cyfra 21-1 in cervical cancer. Bonfrer JM, Gaarenstroom KN, Kenter GG, Korse CM, Hart AA, Gallee MP, Helmerhorst TJ, Kenemans P. Gynecol Oncol; 1994 Dec; 55(3 Pt 1):371-5. PubMed ID: 7530676 [Abstract] [Full Text] [Related]
15. [SCC (squamous cell carcinoma) antigen as a tumor marker in cervix cancers]. Geyer H, Schwörer D, Pfleiderer A. Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):266-71. PubMed ID: 2721888 [Abstract] [Full Text] [Related]
16. Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix. Bae SN, Namkoong SE, Jung JK, Kim CJ, Park JS, Kim JW, Lee JM, Kim SJ. Gynecol Oncol; 1997 Mar; 64(3):418-24. PubMed ID: 9062143 [Abstract] [Full Text] [Related]
18. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix. Juang CM, Wang PH, Yen MS, Lai CR, Ng HT, Yuan CC. Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449 [Abstract] [Full Text] [Related]
19. CYFRA 21-1 is not superior to SCC antigen and CEA in head and neck squamous cell cancer. Wollenberg B, Jan V, Schmit UM, Hofmann K, Stieber P, Fateh-Moghadam A. Anticancer Res; 1996 Jan; 16(5B):3117-24. PubMed ID: 8920778 [Abstract] [Full Text] [Related]